Background: Murine postoperative ileus results from intestinal inflammation triggered by manipulation-induced mast cell activation. As its extent depends on the degree of handling and subsequent inflammation, it is hypothesised that the faster recovery after minimal invasive surgery results from decreased mast cell activation and impaired intestinal inflammation.
Objective: To quantify mast cell activation and inflammation in patients undergoing conventional and minimal invasive surgery.
Methods: (1) Mast cell activation (ie, tryptase release) and pro-inflammatory mediator release were determined in peritoneal lavage fluid obtained at consecutive time points during open, laparoscopic and transvaginal gynaecological surgery. (2) Lymphocyte function-associated antigen-1 (LFA-1), intercellular adhesion molecule-1 (ICAM-1) and inducible nitric oxide synthase (iNOS) mRNA as well as leucocyte influx were quantified in non-handled and handled jejunal muscle specimens collected during biliary reconstructive surgery. (3) Intestinal leucocyte influx was assessed by 99mTc-labelled leucocyte single photon emission computed tomography (SPECT) – computed tomography (CT) scanning before and after abdominal or vaginal hysterectomy.
Results: (1) Intestinal handling during abdominal hysterectomy resulted in an immediate release of tryptase followed by enhanced interleukin 6 (IL6) and IL8 levels. None of the mediators increased during minimal invasive surgery except for a slight increase in IL8 during laparoscopic surgery. (2) Jejunal ICAM-1 and iNOS mRNA transcription as well as leucocyte recruitment were increased after intestinal handling. (3) Leucocyte scanning 24 h after surgery revealed increased intestinal activity after abdominal but not after vaginal hysterectomy.
Conclusions: This study demonstrates that intestinal handling triggers mast cell activation and inflammation associated with prolonged postoperative ileus. These results may partly explain the faster recovery after minimal invasive surgery and encourage future clinical trials targeting mast cells to shorten postoperative ileus.
Statistics from Altmetric.com
Postoperative ileus, characterised by a lack of coordinated motility of the entire gastrointestinal tract, leads to increased morbidity and prolonged hospitalisation,1 2 and represents a substantial socio-economical burden. In the USA alone, the additional annual healthcare expenses related to this condition have been estimated to surpass US$1 billion.3 At present, treatment is rather disappointing and limited to predominantly supportive measures.4
The introduction of minimal invasive surgical techniques (eg, laparoscopy) has speeded up postoperative recovery significantly.5 This major improvement is believed to result from minimal wound trauma and decreased release of stress hormones.6 7 In addition, it is becoming increasingly clear that intestinal inflammation is a key event in the pathogenesis of postoperative ileus. In rats, the degree of gut paralysis is directly proportional to the degree of intestinal handling and inflammation.8 This inflammation leads to local impaired muscle contractility9 and the activation of an adrenergic inhibitory neural pathway.10 Reduction of inflammatory cell influx accomplished by blockade of adhesion molecules shortens postoperative ileus10 11 and further underscores the importance of this handling-induced inflammation. As minimal invasive surgery implies limited handling of the intestine, faster recovery of motility may result from an impaired influx of inflammatory cells.
Although the exact mechanism remains unclear, we previously showed that mast cells play a pivotal role in triggering the inflammatory process. In mice, intestinal handling led to degranulation of mast cells with increased levels of mouse mast cell protease-1 in peritoneal lavage fluid. In contrast, W/Wv mice, deficient in mast cells, failed to develop an intestinal muscle inflammation in response to manipulation of a bowel loop. Reconstitution of W/Wv mice with mast cells from wild-type animals restored the handling-induced inflammatory response, clearly demonstrating the importance of mast cells. Activation of resident macrophages has also been demonstrated, possibly secondary to influx of luminal bacteria during a brief episode of increased mucosal permeability.12 To what extent mast cell activation is the trigger leading to increased mucosal permeability and macrophage activation remains to be determined.
At present, the evidence supporting the importance of inflammation in humans is rather scarce,13 and data on the relationship between the degree of inflammation and clinical outcome are lacking. In addition, although we provided convincing evidence for a crucial role for mast cell degranulation in mice, no data are available in man. In the present study, therefore, we examined whether intestinal manipulation leads to mast cell degranulation and inflammation in patients undergoing conventional or minimal invasive surgery and hypothesised that clinical recovery is determined by the degree of manipulation-induced mast cell activation and inflammation.
PATIENTS AND METHODS
Between December 2003 and July 2005 a total of 44 patients were enrolled in three clinical research protocols. The physical condition and comorbidity of potential participants were assessed during preassessment at the outpatient clinic of the department of anaesthesiology, which is part of the standard preoperative work-up. The American Society of Anesthesiologists-Physical Status classification (ASA-PS)14 15 was used and comprises a scale from 1 to 6 in which 1 equals a normal healthy patient; 2 equals a patient with mild systemic disease; 3 equals a patient with severe systemic disease; 4 is a patient with severe systemic disease that is a constant threat to life; 5 equals a moribund patient who is not expected to survive without the operation; and 6 equals a declared brain-dead patient whose organs are being removed for donor purposes.14 In the present study, only patients categorised as ASA-PS 1–3 were asked to participate. In addition, patients were screened for the following exclusion criteria: intra-abdominal inflammation, preoperative radiation therapy and the use of anti-inflammatory or mast cell-stabilising drugs. Patients were included after informed consent was obtained.
The activation of mast cells and the inflammatory mediator response to intestinal handling were evaluated in protocol 1 (see below). Proinflammatory gene transcription and leucocyte recruitment within the handled intestinal muscle layer were studied in protocol 2. The occurrence of manipulation-induced leucocyte recruitment in relation to clinical recovery of bowel function and duration of hospital admission was evaluated in study protocol 3. All protocols were evaluated and approved by the Medical Ethical Review Board of the Academic Medical Center, Amsterdam, The Netherlands.
To correct for the influence of the anaesthetic technique and medication used, patients were subjected to standardised perioperative care according to our anaesthesiologist’s protocol. In brief, patients were premedicated with paracetamol 1000 mg and lorazepam 1 mg on the evening before surgery and approximately 2 h before surgery. Induction of general anaesthesia was attained with propovol 2–2.5 mg/kg; fentanyl 1.5–3 μg/kg; rocuronium 0.6 mg/kg. Anaesthesia was maintained using end-tidal. 0.8% isoflurane. Postoperative pain medication was introduced after the last sampling in protocols 1 and 2 and was administered in a similar way to all patients according to our anaesthesiologist’s pain protocol.
Protocol 1: mast cell activation and inflammatory mediator release during abdominal surgery
Peritoneal lavage fluid samples were collected from 18 patients, undergoing either an abdominal hysterectomy (n = 6), a laparoscopic resection of an adnexum (n = 6) or a transvaginal hysterectomy (n = 6). Three consecutive lavages were performed in each individual patient. The first lavage sample was collected immediately after opening of the peritoneum (basal). A second lavage sample was collected immediately after abdominal inspection and first gentle small intestinal handling (early). The final lavage sample was collected at the end of the procedure (late). As the intestine is not handled in the transvaginal hysterectomy group, only two lavages were performed in this group (ie, basal and late sampling). The systemic release of mediators in response to abdominal surgery was assessed in two blood samples (abdominal hysterectomy only), the first sample taken before induction of general anaesthesia (1 day prior to surgery) and the second sample taken at the end of the surgical procedure—that is, just before closure of the abdominal cavity. The harvested fluid and serum were used to measure the release of tryptase, tumour necrosis factor α (TNFα), interleukin 1β (IL1β), IL6 and IL8 in relation to surgical handling. The abdominal lavage was performed using 100 ml of warm (42°C) sterile 0.9% NaCl solution, which was sprinkled gently onto the small intestine and its mesentery. After approximately 30 s, peritoneal fluid (between 20 and 40 ml) was collected using a 22 French Foley catheter (Bard Limited, West Sussex, UK) connected to a 50 ml catheter tip syringe.
Protocol 2: regulatory gene transcription and leucocyte influx upon intestinal handling
Jejunal muscle specimens were used to quantify regulatory gene transcription and assess the degree of inflammation. Full-thickness biopsies were obtained from patients undergoing biliary reconstructive surgery. This specific procedure was chosen because of its considerable length, providing at least sufficient time for gene transcription to occur.16 Two consecutive jejunal tissue samples were collected from 10 patients. The first specimen was collected at the beginning of the procedure and had not been touched by the surgeon until resection. The second tissue specimen, exposed to the usual handling during surgery, was collected approximately 3 h later. Following mucosa removal, both specimens were partitioned (5 mm2 segments) and snap-frozen in liquid nitrogen in the operating theatre, and stored at −80°C.
Protocol 3: abdominal leucocyte recruitment and clinical recovery
Abdominal leucocyte single photon emission computed tomography (SPECT) – computed tomography (CT) scans were performed in 16 gynaecological patients to quantify the leucocyte recruitment in response to surgical handling. Eight patients undergoing an abdominal hysterectomy were compared with eight patients undergoing a vaginal hysterectomy. In each patient, a reference (basal) leucocyte scintigraphy was performed on the day of admission, 24 h prior to surgery. A second leucocyte scintigraphy was performed on the first postoperative day—that is, approximately 24 h after surgery. Clinical recovery was assessed until hospital discharge (see below for a detailed description).
Tryptase concentrations were assessed at the routine clinical laboratory of the Department of Allergy, University Medical Center, Groningen, The Netherlands. The total tryptase (α-protryptase and β-tryptase) concentration was measured in peripheral blood and lavage fluid samples using a commercial fluoro-immunoenzyme assay (FIA) (Pharmacia Uppsala, Sweden).17
Cytokine and chemokine release
Cytokine levels were determined by cytometric bead array (BD PharMingen, San Diego, CA). In brief, 5 μl of each test sample was mixed with 5 μl of mixed capture beads and 5 μl of human phycoerythrin (PE) detection reagents consisting of PE-conjugated anti-human IL1β, TNFα, IL6 and IL8. These mixtures were incubated at room temperature in the dark for 3 h, washed and resuspended in 300 μl of wash buffer. Acquisition was performed on a FACSCalibur using a high-throughput sampling interface (BD Biosciences, Sunnyvale, CA). Generated data were analysed using CBA software (BD PharMingen) and interpolated from corresponding standard curves generated using the mixed cytokine standard provided by the supplier.18 19
Real-time reverse transcription-PCR
Tissue specimens were homogenized and total RNA was extracted using Trizol (Invitrogen, Carlsbad, CA). The total RNA fractions were treated with DNase and reverse-transcribed using Superscript II (Invitrogen). cDNA (150 ng) was subjected to 45 cycles of lightcycler PCR (FastStartDNA Masterplus SYBR Green; Roche, Basel Switzerland). The following primers were used: lymphocyte function-associated antigen-1 (LFA-1) antisense 5′-GACCCAAGTGCTCTCAGGAA-3′ and sense 5′-AGGAGCACTCCACTTCATGC-3′; intercellular adhesion molecule-1 (ICAM-1) antisense 5′-CATAGAGACCCCGTTGCCTA-3′ and sense 5′-GGGTAAGGTTCTTGCCCACT-3′; inducible nitric oxide synthase (iNOS) antisense 5′-TGGAAGCGGTAACAAAGGAGA-3′ and sense 5′-CGATGCACAGCTGAGTGAAT-3′; and glyceraldehyde phosphate dehydrogenase (GAPDH) antisense 5′-CGACCACTTTGTCAAGCTCA-3′ and sense 5′-AGGGGAGATTCAGTGTGGTG-3′. PCR quantification was performed by a linear regression method using the Log(fluorescence) per cycle number20 and normalised for GAPDH housekeeping gene expression. In each individual patient, the late sample value was expressed as fold increase of the early control sample value.
Immunocytochemical staining was performed on peritoneal cell cytospins obtained from the harvested abdominal lavage fluid. In brief, spins containing 1×105 cells were fixed in Carnoy’s fixation fluid (60% ethanol, 30% chloroform and 10% glacial acidic acid) for 30 min at room temperature and washed with Tris-buffered saline–Tween (TBST; 0.1%). Non-specific binding of antibody was blocked by incubation with TBS containing 10% normal goat serum for 20 min. Spins were incubated with anti-tryptase antibodies (mouse anti-human, 1:250) (Chemicon, Temecula, CA) for 2 h at room temperature. Goat anti-mouse Alexa-488 was used as secondary antibody (Molecular Probes, Invitrogen). After final washing, the spins were mounted using Vectashield mounting medium containing 5 μg/ml 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA).
Semi-quantitative evaluation of the degree of intestinal muscle inflammation
Handled and non-handled jejunal muscle sections were used to assess the extent of inflammation. Leucocyte infiltration was visualised by myeloperoxidase (MPO) staining as described previously.11 After 10 min fixation in ice-cold acetone, transverse frozen sections (8 μm) were incubated for 10 min with 3-amino-9-ethyl carbazole (Sigma, St Louis, MO) as a substrate, disolved in sodium acetate buffer (pH 5.0) to which 0.01% H2O2 was added.10
To evaluate the degree of inflammation, unmarked myeloperoxidase-stained early and late collected sections from 10 patients were scored independently by three observers (T.K., O.W. and R.vd W.). A semi-quantitative scoring scale from 0 to 4 was utilised, 0 being non-inflamed, 1, very mildly inflamed; 2, mildly inflamed; 3, inflamed; and 4, clearly inflamed. The mean of three scores, calculated for each segment, was used for statistical analysis (Wilcoxon signed rank test).
In vivo quantification of leucocyte recruitment
White blood cells (WBCs) were labelled using technetium-99m hexamethylpropyleneamine oxime (99mTc-HMPAO) (Ceretec, GE Health, Eindhoven, The Netherlands) according to the consensus protocol for leucocyte labelling.21 The harvested WBC fraction of 100 ml of blood labelled with an average of 450±10 MBq of 99mTc-HMPAO was reinjected into the patient. Sixty min later, a SPECT scan of the abdomen was performed (GE Millennium Hawkeye, GE Healthcare, Den Bosch, The Netherlands) followed by a low-dose CT scan without contrast on the same gantry. CT data were used for attenuation correction and as an anatomical reference for region of interest (ROI) analysis. After data acquisition, images were processed on an Entegra workstation (GE Healthcare) using attenuation-corrected iterative reconstruction and analysed on a Hermes workstation (Nuclear Diagnostics, Stockholm, Sweden). Five consecutive abdominal SPECT slices were summed and ROIs were drawn around the small intestine and lumbar spine at the level of the ileac crest. Small bowel uptake of leucocytes was calculated as an uptake ratio expressed as a fraction of bone marrow activity, similar to analysis of leucocyte uptake assessment in inflammatory bowel disease.22 The small bowel uptake ratio determined prior to surgery was considered as basal leucocyte activity. The relative percentage difference in leucocyte activity 24 h after surgery was calculated using the following formula: (postoperative small bowel ratio/preoperative small bowel ratio)×100%.
All patients received standard postoperative medical care according to the usual ward care protocol. Patients were visited by the research physician once daily until discharge to assess postoperative clinical recovery of bowel function (time of first flatus and time of first defecation). Patients were discharged when the following criteria were met: normal urinary tract function; spontaneous defecation; tolerance of oral fluid and solid food intake; adequate pain relief with oral analgesics; and adequate mobilisation and self-support.
Statistical analysis was performed using SPSS 12.02 software for Windows. Data were non-parametrically distributed and expressed as median values and interquartile range or median increase compared with basal values. In protocol 1, all serum samples but only vaginal hysterectomy lavage samples were analysed using a Wilcoxon signed rank test for two paired samples. For all other lavage sample series (consisting of three samples), a Friedman’s two-way analysis of variance was applied. When a statistical difference was observed, a Mann–Whitney test was used to identify the specific sample(s) showing the significant difference. In protocol 2, the quantitative PCR data and the semi-quantitative inflammation data were analysed using a Wilcoxon signed rank test. In protocol 3, leucocyte recruitment was analysed using the Wilcoxon signed rank test. Clinical data were analysed with a Mann–Whitney test for independent samples. P-values <0.05 was considered statistically significant.
Eighteen patients participated in study protocol 1, six in each surgical intervention group. Overall mean age was 47 years, range 21–70 (transvaginal, 52 years, range 43–70; laparoscopy, 36 years, range 21–49; laparotomy, 49 years, range 44–53). The indications for surgery in this patient population were leiomyomata (n = 8), prolapse (n = 4) or a benign ovarian tumour (n = 6). In study protocol 2, jejunal tissue samples were collected from 10 patients (6 male, mean age 42 years, range 32–53) who underwent biliary reconstructive surgery because of iatrogenic biliary tract injury. Study protocol 3 involved 16 patients; eight patients underwent an abdominal hysterectomy (mean age 50 years, range 42–70) and eight patients underwent a vaginal hysterectomy (mean age 55 years, range 42–66). The indications for surgery were uterine leiomyomata in the abdominal hysterectomy patient group and uterine prolapse (n = 4), leiomyomata (n = 3) and primary dysmenorrhoea (n = 1) in the vaginal hysterectomy group.
Study protocol 1
Mast cell activation and inflammatory response during abdominal surgery
To assess the activation of mast cells in response to intestinal handling, the expression and release of tryptase, a prestored mast cell-specific protease,23 was analysed. Peritoneal lavage fluid harvested during abdominal surgery (laparotomy) contained a distinct mast cell population, as illustrated by the number of tryptase-positive cells in fig 1A. In the basal lavage sample collected immediately after opening of the peritoneal cavity, the basal median tryptase concentration was 5.2 (interquartile range (IQR) 2.7–11.3) μg/l. Tryptase release was significantly increased to a median concentration of 23.1 (IQR 15.1–46.9) μg/l, (p = 0.02) in early samples taken after gentle palpation of the small intestines, necessary to allow inspection of the pelvic organs. In the late sample taken at the end of surgery, tryptase levels had increased even further (late: median concentration 51.7 (IQR 25.8–90.2) μg/l, n = 6, p = 0.002) (fig 1B). In contrast, neither laparoscopic nor transvaginal intraperitoneal surgery (n = 6 in both types of surgery) elicited a significant mast cell response (fig 1C,D). To evaluate possible release of mast cell mediators in the systemic circulation, we also determined preoperative and postoperative serum tryptase concentrations in the laparotomy group (n = 6 patients). Serum tryptase levels did not increase and remained within the normal range of 1–11.4 μg/l24 (preoperative median concentration 4.1 (IQR 2.8–7.5) μg/l and postoperative 1.6 (IQR 1.3–3.5) μg/l, respectively).
The release of the proinflammatory cytokines TNFα, IL1β and IL6, and of the chemokine IL8 was analysed in the same peritoneal lavage samples. Gentle handling of the intestine during laparotomy did not lead to an immediate increase in any of these mediators. However, at the end of the surgical procedure, IL6 and IL8 were increased significantly (table 1). In laparoscopically treated patients, intraperitoneal IL8, but not IL6, was increased, but not as profound as in the laparotomy group (table 1). On the other hand, transvaginal surgery did not affect any of the measured cytokines and chemokines. TNFα and IL1β levels did not change upon first handling or at the end of any of the types of surgery evaluated.
The serum levels of the studied inflammatory mediators remained unaltered (median increase compared with preoperatively for: TNFα, 0.0 (IQR 0.0–0.0) pg/ml; IL1β, 0.0 (IQR 0.0–35.3) pg/ml; IL6, 4.2 (IQR 0.0–11.7) pg/ml; IL8, 0.9 (IQR 0.0–310.4) pg/ml).
Study protocol 2
Regulatory gene transcription upon intestinal handling
Recruitment of leucocytes to the muscularis propria strongly depends on the upregulation of adhesion molecules and the synthesis of proinflammatory proteins. Therefore, ICAM-1, LFA-1 and iNOS gene expression was determined in muscle specimens collected during abdominal surgery. As the synthesis of functional proteins requires several hours,16 mRNA quantification was used to evaluate the kinetics of these inflammatory proteins in jejunal muscle tissue. As shown in Table 2, iNOS and ICAM-1 levels were significantly increased after intestinal handling (table 2). In contrast, LFA-1 remained unchanged.
Degree of intestinal muscle inflammation upon intestinal handling
Histological evaluation of leucocyte recruitment was performed before and after surgical handling on the same tissue specimens used for gene transcription analysis. Myeloperoxidase was stained to visualise leucocyte recruitment in response to intestinal handling in transverse sections of the jejunal muscularis propria. Non-handled early samples contained only a small number of leucocytes in the muscle layer (fig 2A upper panel). In contrast, routinely handled late specimens showed a marked extravasation of inflammatory cells (fig 2A lower panel), confirmed by semi-quantitative evaluation (fig 2B). These recruited leucocytes predominantly reside in and around the vasculature of the handled intestinal muscle layers, as is illustrated in fig 2B. This extravasation marks the ongoing inflammatory process.
Study protocol 3
Abdominal leucocyte recruitment 24 h after open and minimal invasive hysterectomy
In vivo leucocyte recruitment in response to intestinal handling was investigated by 99mTc-labelled leucocyte imaging. Abdominal leucocyte influx was assessed on five consecutive leucocyte SPECT images at the level of the ileac crest and compared with that of the bone marrow.22 The change in leucocyte activity before compared with after surgery showed no increase in the vaginal hysterectomy group (median percentage activity before compared with after surgery, 91% (IQR 84–102), n = 8). In the abdominal hysterectomy group, however, leucocyte recruitment was significantly increased to a median of 127% of the preoperative abdominal activity ((IQR 113–148), n = 8, p = 0.01) (fig 3). To determine the exact anatomical location, plain CT images were made immediately after SPECT imaging. The region in which the enhanced leucocyte activity was observed coincided with small intestinal loops and its mesentery, as shown in fig 4.
Clinical recovery after open and minimal invasive hysterectomy
In conjunction with the assessed leucocyte recruitment, clinical recovery was also evaluated. Time until first flatus did not differ significantly between the two patient groups. First bowel movement and duration of hospital admission, however, were significantly prolonged after abdominal hysterectomies compared with the vaginal procedure (table 3).
Inflammation of the muscularis propria following surgical manipulation of the intestine is increasingly recognised to delay the recovery of gastrointestinal motility. Animal studies have revealed that prevention of this inflammatory process, by either antibodies or antisense oligonucleotides to the adhesion molecule ICAM-1, macrophage inactivation or cyclo-oxygenase-2 (COX-2) inhibition, enhances gastrointestinal transit and shortens postoperative ileus.11 25–27 Recently, we demonstrated that mast cell activation plays an important role in this process and may be one of the first steps triggering the inflammatory response. Intestinal manipulation indeed induces the immediate activation of mast cells, leading to increased levels of the murine mast cell proteinase-1 in the abdominal cavity.25 Three hours later, inflammatory mediators such as macrophage inflammatory protein (MIP)-2, MIP-1α, ΤΝFα and IL6 can be detected,27 28 which in their turn enhance the expression of adhesion molecules such as ICAM-1,11 recruitment of leucocytes and inflammation of the intestine.
In the present study, we investigated whether this cascade of events also plays a role in the pathogenesis of human postoperative ileus. We found that gentle palpation of the intestines during first inspection of the pelvic organs resulted in the instantaneous intraperitoneal release of tryptase, a mast cell-specific protease,23 in patients undergoing a laparotomy. This increase in tryptase increased even further towards the end of the procedure and was accompanied by an increase in IL6 and IL8. As the latter is known to be released in response to mast cell activation and initiates leucocyte recruitment via ICAM-1,29 we also determined ICAM-1 and iNOS mRNA in intestinal tissue that was handled at the start of a surgical procedure, but was only removed approximately 3 h later. In addition to an upregulation of ICAM-1 and iNOS, the number of inflammatory cells was significantly increased in these late tissue samples compared with untouched specimen harvested at the beginning of the procedure. Interestingly, leucocytes were localised predominantly around blood vessels in both the serosa and the muscularis propria, partly adhering to the endothelial lining marking the ongoing recruitment and extravasation in this early stage of inflammation. Kalff et al also reported an intestinal inflammatory response during abdominal surgery in patients.13 To assess the degree of inflammation in a later stage, we also performed 99mTc-labelled leukocyte SPECT scanning 24 h after surgery. Using this technique, we showed increased intra-abdominal activity compared with the preoperative baseline scan in patients subjected to an abdominal hysterectomy. As the actual resection, performed in the pelvic region, did not involve any gastrointestinal organs, this observed increase in leucocyte activity cannot be explained by the primary surgical trauma. Clearly, leucocytes could reside anywhere in the abdominal cavity and may not be restricted to the intestinal wall. The additional CT scanning, however, showed that the increased leucocyte activity observed with the SPECT scans coincided with intestinal loops. When the uterus was resected transvaginally, a surgical approach that leaves the intestines largely untouched, no such increase was observed, indirectly suggesting that the intestinal inflammation is triggered by intestinal manipulation. From these data, we conclude that also in man, manipulation of the intestine during surgery leads to mast cell degranulation and a local inflammatory process, which, as in our animal model, plays an important role in postoperative hypomotility.
In rodents, the extent of gastrointestinal hypomotility or ileus is proportionally related to the degree of intestinal handling and subsequent inflammation.8 As intestinal manipulation is minimal in laparoscopic surgery, one might argue that the degree of mast cell degranulation and the subsequent inflammatory response in the intestine will be less and thus may contribute to the faster clinical recovery observed after minimal invasive surgery. To test this hypothesis, tryptase and inflammatory mediators were quantified during two minimal invasive surgical procedures—that is, laparoscopic and transvaginal hysterectomy. In contrast to gentle handling during open surgery, no mast cell degranulation or increase of IL6 was observed in the peritoneal lavage fluid. Only IL8 levels were increased, although to a lesser extent compared with laparotomy. Moreover, during transvaginal surgery, leaving the intestines largely untouched, none of the evaluated parameters increased. These findings underscore that the degree of intestinal handling to a large extent determines the degree of mast cell activation and the subsequent inflammatory response. The latter was further confirmed by the 99mTc-labelled leucocyte SPECT scanning 24 h after surgery showing increased intra-abdominal activity in patients subjected to an abdominal hysterectomy but not in patients who underwent a transvaginal hysterectomy. Finally, clinical recovery in our study was significantly delayed after abdominal compared with vaginal hysterectomy, a finding in line with previous clinical studies showing faster postoperative gastrointestinal recovery after minimal invasive surgery.6 30–35 It should be emphasised, however, that differences in postoperative pain medication, especially opioids, may have contributed to the delay in normalisation of gastrointestinal motility.36 37 In the current study, however, postoperative analgesia in both patient groups was provided according to a standardised postoperative pain protocol, making this explanation less likely. Therefore, the observation that delayed clinical recovery is associated with increased influx of radiolabelled leucocytes indirectly adds to the hypothesis that the degree of intestinal handling, mast cell degranulation and subsequent inflammation determines the duration of postoperative ileus.
A drawback of this study is that the study protocols were conducted in different groups of patients. Ideally, the same patient cohort should have been studied in order to understand better the causative association between mast cell degranulation and the subsequently observed inflammatory responses upon intestinal handling. In particular, as mRNA levels of ICAM-1 and iNOS peak only 2–24 h after stimulation,16 38 a long-lasting surgical procedure had to be chosen in order to allow the detection of the upregulation of these inflammatory markers in response to intestinal handling. Therefore, patients undergoing biliary reconstructive surgery were selected instead.
Our current findings may have important clinical implications. First, they clearly illustrate that manipulation of the intestine should be limited whenever possible in order to reduce the release of mast cell mediators and limit postoperative intestinal inflammation. This knowledge should encourage further development of minimal invasive surgical or even endoscopic techniques to minimise intestinal handling. Secondly, if mast cell degranulation is indeed an important initial step in the pathophysiology of postoperative ileus in man, mast cells may represent an important therapeutic target. As we previously showed reduction of postoperative ileus by mast cell stabilisation in our mouse model, our current findings in humans warrant further studies evaluating the effect of a mast cell-stabilising agent in patients.
We would like to thank Professor M.P.M. Burger and Dr M. van Beurden for their support in realising the studies in the Department of Gynaecology, Professor M.W. Hollmann for anaesthesiological support and intellectual input, F. van Hemert, C. Veeris and J. de Jong for the WBC labelling, the Nuclear Medicine technicians and staff for the SPECT and CT imaging, and A. Groot for her support in the laboratory.
Funding: Supported by the Technology Foundation STW, Applied Science Division of NWO, and the Technology Program of the Ministry of Economic Affairs (NWO-STW, grant AKG 5727 to F.O.T. and R.vd W.).
Competing interests: None.